High-Dose Chemotherapy with Stem Cell Rescue
Treatment for Malignant Neoplasm Of Bone And Articular Cartilage
Typical Dosage: Supra-myeloablative doses of various chemotherapeutics
Effectiveness
65%
Safety Score
25%
Clinical Trials
50
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
Supra-myeloablative doses of various chemotherapeutics
Time to Effect
Weeks (engraftment and initial recovery), months for full recovery
Treatment Duration
1-3 months inpatient, prolonged outpatient recovery
Evidence Quality
MODERATEConfidence Score
70%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75,000
Monitoring:$75,000
Side Effect Mgmt:$50,000
Total Annual:$200,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORICER
$250,000/QALY
QALYs Gained
2
Outcome-Based Costs
Cost per Responder
$500,000
Cost per Remission
$666,667
Comparison vs Conventional Salvage Chemotherapy
Cost Difference
+$100,000/year
More expensive
QALY Difference
+0.50 QALYs
Better outcomes
Dominance
No dominance
High-Dose Chemotherapy with Stem Cell Rescue Outcomes
for Malignant Neoplasm Of Bone And Articular Cartilage
Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+40%
Remission Rate
+30%
Common Side Effects
Profound Myelosuppression (infection, bleeding)
+95%
Severe Mucositis
+80%
Organ Toxicity (cardiac, renal, hepatic)
+40%
Graft-versus-host disease (allogeneic transplant)
+50%
Mortality
+7%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov